Net Cash Provided by (Used in) Investing Activities of CHAMPIONS ONCOLOGY, INC. from 31 Jul 2010 to 31 Jul 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary: CHAMPIONS ONCOLOGY, INC. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Jul 2010 to 31 Jul 2025.
CHAMPIONS ONCOLOGY, INC. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Jul 2025 was $46,000.
CHAMPIONS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $389,000, a 53% increase from 2023.
CHAMPIONS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $836,000, a 71% increase from 2022.
CHAMPIONS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $2,872,000, a 20% decline from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Investing Activities, Annual (USD)

Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$46,000	-$46,000		01 May 2025	31 Jul 2025	10-Q	15 Sep 2025	2026	Q1
Q2 2024	$0	+$668,000		01 May 2024	31 Jul 2024	10-Q	15 Sep 2025	2026	Q1
Q2 2023	$668,000	+$86,000	+11%	01 May 2023	31 Jul 2023	10-Q	13 Sep 2024	2025	Q1
Q2 2022	$754,000	+$153,000	+17%	01 May 2022	31 Jul 2022	10-Q	13 Sep 2023	2024	Q1
Q2 2021	$907,000	-$281,000	-45%	01 May 2021	31 Jul 2021	10-Q	12 Sep 2022	2023	Q1
Q2 2020	$626,000	+$123,000	+16%	01 May 2020	31 Jul 2020	10-Q	13 Sep 2021	2022	Q1
Q2 2019	$749,000	-$538,000	-255%	01 May 2019	31 Jul 2019	10-Q	14 Sep 2020	2021	Q1
Q2 2018	$211,000	+$699,000	+77%	01 May 2018	31 Jul 2018	10-Q	16 Sep 2019	2020	Q1
Q2 2017	$910,000	-$893,000	-5253%	01 May 2017	31 Jul 2017	10-Q	14 Sep 2018	2019	Q1
Q2 2016	$17,000	+$12,000	+41%	01 May 2016	31 Jul 2016	10-Q	14 Sep 2017	2018	Q1
Q2 2015	$29,000			01 May 2015	31 Jul 2015	10-Q	14 Sep 2016	2017	Q1
Q2 2013	$40,000	-$21,000	-111%	01 May 2013	31 Jul 2013	10-Q	13 Sep 2013	2014	Q1
Q2 2012	$19,000	+$76,000	+80%	01 May 2012	31 Jul 2012	10-Q	13 Sep 2013	2014	Q1
Q2 2011	$95,000	-$75,000	-375%	01 May 2011	31 Jul 2011	10-Q	12 Sep 2012	2013	Q1
Q2 2010	$20,000			01 May 2010	31 Jul 2010	10-Q	13 Sep 2011	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$389,000	+$447,000	+53%	01 May 2024	30 Apr 2025	10-K	23 Jul 2025	2025	FY
2023	$836,000	+$2,036,000	+71%	01 May 2023	30 Apr 2024	10-K	23 Jul 2025	2025	FY
2022	$2,872,000	-$488,000	-20%	01 May 2022	30 Apr 2023	10-K	19 Jul 2024	2024	FY
2021	$2,384,000	+$785,000	+25%	01 May 2021	30 Apr 2022	10-K	24 Jul 2023	2023	FY
2020	$3,169,000	-$949,000	-43%	01 May 2020	30 Apr 2021	10-K	22 Jul 2022	2022	FY
2019	$2,220,000	-$1,386,000	-166%	01 May 2019	30 Apr 2020	10-K	26 Jul 2021	2021	FY
2018	$834,000	+$392,000	+32%	01 May 2018	30 Apr 2019	10-K	28 Jul 2020	2020	FY
2017	$1,226,000	-$460,000	-60%	01 May 2017	30 Apr 2018	10-K	29 Jul 2019	2019	FY
2016	$766,000	-$444,000	-138%	01 May 2016	30 Apr 2017	10-K	30 Jul 2018	2018	FY
2015	$322,000	-$208,000	-182%	01 May 2015	30 Apr 2016	10-K	28 Jul 2017	2017	FY
2014	$114,000			01 May 2014	30 Apr 2015	10-K	29 Jul 2016	2016	FY
2012	$57,000	+$462,000	+89%	01 May 2012	30 Apr 2013	10-K	26 Jul 2013	2013	FY
2011	$519,000	-$435,000	-518%	01 May 2011	30 Apr 2012	10-K	26 Jul 2013	2013	FY
2010	$84,000			01 May 2010	30 Apr 2011	10-K	18 Jul 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.